Elevated CCL20 expression was associated with poor prognosis for breast cancer
These findings highlighted that elevated CCL20 expression was linked to a more aggressive tumor phenotype and a disappointing OS in breast cancer patients, thus advocating for the consideration of CCL20 expression being a novel independent prognostic biomarker for guiding bespoke treatment strategies.
Authors
- Shuzhen Lv
- Yan-Ping Li (ORCID: https://orcid.org/0000-0002-0084-3652)
- Feng Yu (ORCID: https://orcid.org/0000-0002-6751-6111)
- Xia Zhao
Institutions
- Capital Medical University (CN)
- Beijing Shijitan Hospital (CN)
Publication Details
- Journal
- Journal of the Chinese Medical Association
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1097/jcma.0000000000001233
- Citations
- 2
- Primary Topic
- Chemokine receptors and signaling
- Type
- article
- Field-Weighted Citation Impact
- 2.09